Home > Boards > US OTC > Cannabis >

OWC Pharmaceutical Research Corp. (OWCP)

OWCP RSS Feed
Add OWCP Price Alert      Hide Sticky   Hide Intro
Moderator: Blue Skys, Homebrew, PhenixBleu, CanItBThisEZ2Make
Search This Board: 
Last Post: 7/24/2021 7:28:38 AM - Followers: 1089 - Board type: Free - Posts Today: 1


David Kugelman has been appointed Sole Director of the OWC Pharmaceutical Research Corp and One World Cannabis Ltd.
 

"Transforming cannabis into scientifically proven and clinically approved medical solutions"

U.S. Patent 10,603,301 Issued March 31, 2020 - Cannabis-Based Extracts and Topical Formulations for Use in Skin Disorders



-- NATIONAL INSTITUTE OF HEALTH CLINICAL TRIALS --



OWC Pharmaceutical Research Corp. (OWCP)
A Delaware Corporation since March 6, 2008

11 Anne Frank Street
Petah Tikva, Israel 4931113




DELINQUENT SEC REPORTING


         
EDGAR FACEBOOK OTC PROFILE TWITTER WEBSITE
 


OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One World Cannabis Ltd. ("OWC"), of conducting
medical research and clinical trials, in full compliance with all international regulatory protocols, for the development and improvement of strains of medical cannabis
specifically designed for the treatment of several illnesses/medical conditions including Multiple Myeloma, Psoriasis, Fibromyalgia, Migraine, and PTSD.

 Our business plan includes entering into collaborative ventures with major medical centers and highly regarded researchers in Israel and potentially
other countries with the goal of developing novel therapeutic methods for the treatment of serious medical conditions with cannabis-based therapies and are
conducting pre-clinical investigations and randomized, placebo-controlled trials of cannabis-based compounds and develop unique, condition-specific products.

 

AUTHORIZED  500,000,000 OUTSTANDING  497,498,338 FLOAT  206,509,849
TA Verified 07/01/20 TA Verified 07/01/20 02/09/20


-- Leadership --

DAVID KUGELMAN

Mr. Kugelman, age 56, is the President of Atlanta Capital Partners, LLC, a private equity and investor relations consulting firm, and the Publisher of the small-cap stock newsletter, OTC Stock Review. Mr. Kugelman has been in the Investment industry since 1986 and has held the National Association of Securities Dealers Series 7, 24, 63, and 66 licenses, as well as the Certified Financial Manager designation. In the past, he has worked for Thomson McKinnon, Bear Stearns, and Merrill Lynch, as well as two regional Investment Banking Firms. In addition to managing investments for both individuals and corporate clients, Mr. Kugelman structured transactions servicing middle market institutional funds by providing corporate clients access to public financial markets including external funding, strategic alliances, restructurings, acquisitions, and business strategy formation.

At Merrill Lynch, Mr. Kugelman was a Financial Advisor and Investment Advisor Representative working mainly with middle market institutional funds, corporations, family offices and Defined Benefit plans. Acting in a financial advisory role, he specialized in retirement and estate planning, tax and asset strategies, philanthropic vehicles, and banking and lending services. A fondness for the pursuit of growth-stocks prompted Mr. Kugelman to leave Merrill Lynch in February, 2003 and formed Atlanta Capital Partners, LLC.

As President of Atlanta Capital Partners, LLC, Mr. Kugelman has provided strategic business planning and public relations services to a diverse number of small and large public and privately held companies. Atlanta Capital Partners, LLC takes a unique approach to investor relations by becoming an investor in a company. Drawing on over 30 years of contacts in the investment industry, Mr. Kugelman has carefully built relationships worldwide with Retail Brokerage Firms, Investment Bankers, Analysts, Fund Managers, and Independent Investors by introducing them to undiscovered opportunities.  

-- Research --
 


Therapies for Skin Diseases
 
Delivery System for Pain Management Multiple Myeloma



--Intellectual Property--

ALL PUBLISHED PATENT APPLICATIONS NAME ONE WORLD CANNABIS AS THE ASSIGNEE (OWNER)

OWCP's Intellectual Property Portfolio comprises 9 patent families and includes 31 filings in selected domains at various stages from PCT filings, National Phase filings
and Continuations in Part (CIP).  The National Phase is the second of the two main phases of the Patent Cooperation Treaty (PCT) procedure. It follows the international phase and consists
of the processing of the international application before each office of or acting for a contracting state of the PCT that has been designated in the international application.

The table below will be updated when the  unknown patent families and additional patent applications are identified.

RICHTER & SHIMONI
OWC's main Patent Agency located in Israel, Germany and Switzerland
Richter engages patent lawyers in other domains for filing purposes
Dr. Gila Shimoni is primary author/editor of patent application content


BROWDY & NEIMARK'S WEBSITE (USPTO)
Browdy is OWC's U.S. Intellectual Property Law Firm

DENNEMEYER & CO. WEBSITE (AUSPAT)

Chronic Pain - Emulsions
ACTIONS TAKEN WITHIN PAST 30 DAYS

PATENT GRANTS
     AUSPAT (Australia) (AU)     Canadian Intellectual Property Office (CA)    Czech IPO (CZ)    European Patent Register (EPR)    Israel Patent Office (IL)     US Patent & Trademark Office (USPTO)       WIPO Patentscope (WIPO)
To search for USPTO Patent records, enter the Application Number in the search field.  View documents under Image File Wrapper tab.  To download, check the box in far right column, then click on PDF button above it.

Count Patent Family Invention Name Application No. Filing
Date
Filing
Domain
Application
Published
Last Action Last Action Date Patent No. Patent Granted
1   Multiple Myeloma 1 Novel Cannabinoid Combination Therapies for Multiple Myeloma (MM) PCT/IL2016/050608 06.09.2016 WIPO 12.15.2016        
2   " 2016276563 06.09.2016 AU 12.15.2016 Exam Report #1 10.01.2020    
3   " 2988869 06.09.2016 CA 12.15.2016 Renewal
Fee Paid
06.09.2020    
4   " 15580718 06.09.2016 USPTO 05.07.2018 Non-Final
Rejection
05.12.2020    
5   " 16807035 06.09.2016 EPR 04.18.2018 Examination Report Received 05.07.2021    
6   " 256209 06.11.2015 IS 02.28.2018 Incoming Correspondence 04.28.2020    
7   Multiple Myeloma 2 Synergistic Use of Cannabis for Treating Multiple Myeloma (MM) PCT/IL2015/051138 11.24.2015 WIPO 02.06.2016        
8   " 15/863,361 11.24.2015 EPR 04.10.2017 Notice drawing attention to fee 01.13.2021 Intent to Grant Intent to Grant
9   " 2015351937 11.24.2015 AU 02.06.2016 Lapsed - Continuation Fee Not Paid 06.08.2021    
10   " 2968929 11.24.2015 CA 02.06.2016 Abandoned
Failure to Request Examination
02.15.2021    
11   " 252504 11.26.2014 IS 07.31.2017 Abandoned 01.20.2021    
12   " 15531047 11.24.2015 USPTO 10.25.2018 Abandonment 10.10.2019    
13   Fibromyalgia Use of Cannabis to Treat Fibromyalgia, Methods and Compositions Thereof PCT/IL2016/050498 05.11.2016 WIPO 11.17.2016        
14   " 2016261707 05.11.2016 AU 11.17.2016 Exam Response Reminder #2 (Exam report #1 was 06/30/2020) 05.06.2021    
15   " 2985969 05.11.2016 CA 11.17.2016 Renewal
Fee Paid
05.07.2020    
16   " 16792308.5 05.11.2016 EPR 03.21.2018 Despatch of Exam Report + Time Limit 02.10.2021    
17   " 15573687 05.11.2016 USPTO 05.03.2018 Abandonment 02.20.2020    
18   " 255615 05.13.2015 IS 01.31.2018 Claims w/marked changes 10.18.2020    
19   Pharmaceutical Emulsions Preparations of Cannabis Emulsions and Methods Thereof   PCT/IL2016/050289 03.17.2016 WIPO 09.22.2016        
20   " 16764344 03.17.2016 EPR 01.24.2018 Renewal
Fee Reminder
05.07.21    
21   " 2982250 03.17.2016 CA 09.22.2016 Renewal
Fee Paid
03.09.2020    
22   " 2016231788 03.17.2016 AU 09.22.2016 Exam Report #1 06.16.2020    
23   " 15708187 09.19.2017 USPTO 02.15.2018 Amendments/RFR Forwarded to Examiner 07.10.2020    
24   " 254598 03.19.2015 IS 11.20.2017 Claims w/Marked Changes 09.21.2020    
25   Migraine Use of Cannabis to Treat Migraine   PCT/IL2015/051184 07.12.2015 WIPO 06.16.2016        
26   " 15533684 06.07.2017 USPTO 10.11.2018 Abandonment 07.11.2019    
27   " EP15863361 11.24.2015 EPR 04.10.2017 Deemed Withdrawn 10.26.2018    
28   Sexual Function Novel Condom Comprising Cannabis Derived Compositions for Enhancement of Sexual Pleasure and Decrease of Erectile Dysfunction Symptoms PCT/IL2015/051220 16.12.2015 WIPO 06.23.2016        
29   " 15536738 16.12.2015 USPTO 12.28.2017 Final Rejection 07.22.2020    
30   " EP15869472 16.12.2015 EPR 06.23.2016 Deemed
Withdrawn
07.27.2018    
31   " 2971144 12.17.2014 CA 06.23.2016 Renewal
Fee Paid
12.02.2019    
32 Skin Disorders Use of Cannabis to Treat Psoriasis* PCT/IL2015/051234 12.21.2015 WIPO 06.30.2016 Deemed
Withdrawn
06.22.2018    
33 Skin Disorders Cannabis-Based Extracts and Topical Formulations for Use in Skin Disorders 2015101908 12.21.2015 AU 06.30.2016 GRANTED   2015101908 11.08.2017
34   " 253066 12.21.2014 IS 08.31.2017 Application w/marked changes 09.03.2020    
35   " 15629230 06.21.2017 USPTO 02.15.2018 GRANTED   10,603,301 03.31.2020
36   " 2971197 06.20.2017 CA 12.20.2018 Renewal
Fee Paid
06.19.2020    
37   " 17178303 06.28.2017 EPR 12.26.2018 Reply to Examination Report 12.24.2020    
38 Skin Disorders Hemp extracts and topical preparations for use in skin disorders 2017-33913 7.14.2017 CZ 10.31.2018 GRANTED     01.01.2019

*The Psoriasis agreement with Sheba Academic Medical Center provides that all intellectual property that is conceived during the course of the research is to be jointly owned by Sheba and One World Cannabis.

 

 
OWCP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
OWCP News: Statement of Ownership (sc 13g) 06/21/2021 06:35:30 AM
OWCP News: Amended Statement of Beneficial Ownership (sc 13d/a) 06/21/2021 06:32:48 AM
OWCP News: Amended Statement of Beneficial Ownership (sc 13d/a) 03/30/2021 05:08:06 PM
OWCP News: Statement of Beneficial Ownership (sc 13d) 02/25/2021 04:01:09 PM
PostSubject
#201543  Sticky Note Just so everyone is clear on what is Butternut Crinklefry 06/19/21 11:28:52 AM
#200459  Sticky Note Discover Growth Fund v. OWC Pharmaceutical Research Corp. PhenixBleu 03/28/21 06:34:11 PM
#131717  Sticky Note And here is the complaint: janice shell 03/07/18 03:31:58 PM
#69890  Sticky Note Board Warning - Please Read: IH Admin [Shelly] 03/10/17 08:29:29 AM
#201816   Thanks PB. This will give us plenty to C to the E 07/24/21 07:28:38 AM
#201815   Declaration of John Burke (Senior trader responsible for PhenixBleu 07/23/21 10:10:39 PM
#201814   [PROPOSED] ORDER GRANTING INJUNCTION PhenixBleu 07/23/21 09:50:27 PM
#201813   Notice of Motion for Summary Judgement PhenixBleu 07/23/21 09:46:00 PM
#201812   sure bud, letitride168 07/23/21 03:00:33 PM
#201811   Just my opinion, but I believe this WILL GP65 07/23/21 01:31:54 PM
#201810   Here comes the flush down the toilet surfgreen 07/23/21 11:00:47 AM
#201809   Where is OWCP in stronger hands ?? Torez 07/23/21 10:25:28 AM
#201807   The last 8K was signed by Kugelman, not BruceLake 07/23/21 08:13:27 AM
#201804   The last 8-K was signed by Turner as I-Glow 07/22/21 05:03:19 PM
#201803   No one made Bignitz borrow the $5 million I-Glow 07/22/21 05:00:12 PM
#201801   A lot has been written about "facts", "gifts" BruceLake 07/21/21 07:30:30 PM
#201798   Oh sorry, I thought you actually had real PhenixBleu 07/21/21 04:15:36 PM
#201797   If you want to be enlightened go to BruceLake 07/21/21 02:44:57 PM
#201796   Dude...I make a hell of a lot of BruceLake 07/21/21 02:33:58 PM
#201795   Buying what at $0.50 - I have heard I-Glow 07/21/21 02:31:05 PM
#201794   Nope. I got that from Butternut Crinklefry...lol. PhenixBleu 07/21/21 02:29:05 PM
#201793   Turner has not disappeared, I know exactly where BruceLake 07/21/21 02:27:46 PM
#201792   Dude...seriously...you're making zero sense. I verify facts before PhenixBleu 07/21/21 02:24:37 PM
#201791   Typical OTC investor blaming everyone but the insiders I-Glow 07/21/21 01:59:32 PM
#201790   What is funny is that you are still I-Glow 07/21/21 01:49:40 PM
#201789   Only? I think it'll go lower :D Trooth 07/21/21 01:31:32 PM
#201788   Wrong again! BruceLake 07/21/21 12:13:55 PM
#201787   That is precisely the point. You are being BruceLake 07/21/21 12:05:00 PM
#201786   I make trade decisions based on verifiable facts. PhenixBleu 07/21/21 10:55:58 AM
#201784   Still your opinion that a .50 buy out facts_matter14 07/21/21 01:27:17 AM
#201783  Restored Unfortunately you are misinformed. Kirkland overplayed his hand BruceLake 07/21/21 01:06:24 AM
#201782   The SEC sucks ,from $3 to nothing .WORTHLESS! swamp boy 07/20/21 08:27:33 PM
#201781   NOW, it's time to decide CanItBThisEZ2Make 07/20/21 05:02:26 PM
#201777   Scam OWC gets flushed down the toilet and surfgreen 07/20/21 11:37:49 AM
#201775   After a long relationship with OWCP ticker, I Potvinsux 07/20/21 10:10:24 AM
#201774   It seems to me this scam has been cbuontempo 07/20/21 09:35:19 AM
#201773   Unfortunately, Turner is in control of the subsidiary. PhenixBleu 07/20/21 08:45:28 AM
#201772   What you see is missing wouldn't be missing PhenixBleu 07/20/21 08:31:35 AM
#201771   All we need is a leader? Changed your BruceLake 07/20/21 08:05:48 AM
#201770   Really? As simple as that? REALLY??? cbuontempo 07/20/21 06:50:07 AM
#201769   The research is spot on. Cannabis treats many PhenixBleu 07/19/21 09:18:55 PM
#201768   And pharma scams like OWCP are good for nothing, Homebrew 07/19/21 09:14:31 PM
#201767   Big Pharma prefers to poison people. Little Pharma PhenixBleu 07/19/21 09:13:25 PM
#201765   How much revenue has the psoriasis patent generated? Unless I-Glow 07/19/21 05:56:49 PM
#201764   Looking very good here to finish emptying what crablover 07/19/21 03:09:39 PM
#201763   don't know bud... letitride168 07/19/21 02:55:54 PM
#201762   I hope it comes soon and they know C to the E 07/19/21 02:52:06 PM
#201761   no bud... letitride168 07/19/21 02:30:51 PM
#201760   $2 mil on the bid right now, one C to the E 07/19/21 01:35:17 PM
#201759   This is funny as hell to watch. Good crablover 07/17/21 09:10:12 AM
#201758   People are selling OWCP so as to get BesaoT35 07/16/21 03:38:59 PM
#201757   Lot of volume happening here daily. Not much C to the E 07/15/21 04:58:11 PM
#201756   IG, I’m not accusing Ziv of anything. He fat_tire 07/15/21 04:15:32 PM
#201755   Did you make this up because you can't I-Glow 07/15/21 03:32:47 PM
PostSubject
Consent Preferences